Thomas M. Razler

Statistics

Publications

Citations

726

H-Index

Active since

2002

Affiliations

Bristol-Myers Squibb (United States)(Current)

Monell Chemical Senses Center

University of Pennsylvania

Arizona State University

Johnson & Johnson (United States)

Thomas M. Razler is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, chemistry, and synthetic medicinal chemistry.

ORCID

Publications per year

2002–2018

Publications

Evolution of the Petasis−Ferrier Union/Rearrangement Tactic: Construction of Architecturally Complex Natural Products Possessing the Ubiquitous <i>cis</i>-2,6-Substituted Tetrahydropyran Structural Element

Amos B. Smith, Richard J. Fox, Thomas M. Razler · Accounts of Chemical Research · 2008 · 128 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Mono-Oxidation of Bidentate Bis-phosphines in Catalyst Activation: Kinetic and Mechanistic Studies of a Pd/Xantphos-Catalyzed C–H Functionalization

Yining Ji, R. Erik Plata, Christopher S. Regens et al. · Journal of the American Chemical Society · 2015 · 126 citations

Natural Sciences, Chemistry, Catalysis +16

A Preparatively Convenient Ligand-Free Catalytic PEG 2000 Suzuki−Miyaura Coupling

Thomas M. Razler, Yi Hsiao, Feng Qian et al. · The Journal of Organic Chemistry · 2008 · 68 citations

Natural Sciences, Chemistry, Catalysis +15

Adventures in Atropisomerism: Total Synthesis of a Complex Active Pharmaceutical Ingredient with Two Chirality Axes

Gregory L. Beutner, Ronald Carrasquillo‐Flores, Yi Hsiao et al. · Organic Letters · 2018 · 60 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +9

Nickel-Catalyzed Synthesis of Quinazolinediones

Gregory L. Beutner, Yi Hsiao, Thomas M. Razler et al. · Organic Letters · 2017 · 54 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13

1–5 of 16